Breast Cancer Stage II
55
17
29
11
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.8%
1 terminated out of 55 trials
91.7%
+5.2% vs benchmark
7%
4 trials in Phase 3/4
27%
3 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (55)
Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer
Abbreviated MBCT for Depression in Older Black or African American Breast Cancer Survivors
Herbs & Supplements in Breast Cancer Usage, Impact, and Personalized Approaches for Diverse Populations
Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection
A Study of the TheraBionic P1 Device in Breast Cancer
A Study of Language Interpretation Solutions for People With Breast Cancer
The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer Patients
Pembrolizumab Adjuvant in Patients With Early-stage Triple Negative Breast Cancer With Residual Disease After Neoadjuvant Pembrolizumab Plus Chemotherapy
Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial
Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)
Virtual Rehabilitation for Cancer Survivors
Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial)
Neoadjuvant, SBRT With Intratumoural Pembrolizumab Followed by Neoadjuvant Chemotherapy in Breast Cancer
Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making
Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer
Effect of Physical Training Program on the Exercise Adherence for Breast Cancer Survivor
A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC